Anagram Therapeutics

Boston, United States

Anagram Therapeutics develops orally delivered enzyme therapies for malabsorption syndromes and nutrient deficiencies.

May 2026

Private Equity

Biotechnology Information Technology Medical Therapeutics

Top Investors

Blackstone Life SciencesCystic Fibrosis FoundationMiller Family Trust

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Anagram Therapeutics

Who are Anagram Therapeutics's investors?

Anagram Therapeutics's investors include Blackstone Life Sciences, Cystic Fibrosis Foundation, Miller Family Trust.

Where is Anagram Therapeutics headquartered?

Anagram Therapeutics is headquartered in Boston, United States.

What does Anagram Therapeutics do?

Anagram Therapeutics develops orally delivered enzyme therapies for malabsorption syndromes and nutrient deficiencies.

What stage is Anagram Therapeutics at?

Anagram Therapeutics is at the Private Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 7, 2026.

MLA

"Anagram Therapeutics — Funding & Investors." VCBacked, May 7, 2026, https://www.vcbacked.co/company/anagram-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Anagram Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/anagram-therapeutics

Wikipedia (cite web)

{{cite web |title=Anagram Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/anagram-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 7, 2026.

Similar Companies in Biotechnology